Lobbying Activity Report

1698-43003

Organization: Hoffmann-La Roche Limited
Associated registration: 9040-1698-36
Lobbying Activity date: 2025-05-16
Arranged a meeting: No
Posted date: 2025-06-09

In-house lobbyists who participated in the lobbying activity: Robyn Henwood
Senior Public Office Holders who were lobbied in this activity: Sue Bouma, Executive Director, Clinical Services & Evaluation
Pharmaceutical, Laboratory & Blood Services Division, Health

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement Branch, Health

Tijana Fazlagic, Executive Director, Therapeutic Assessment&Access
PharmaCare Benefits Branch, Provincial Health Services Authority

Sarah Pugh, Executive Director
Integrated Health Services, Planning& Systems, Health

Ian Rongve, ADM
Pharmaceutical Laboratory & Blood Services Division, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Further promote the contributions and positive impact of pharmaceutical innovation and the pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health, Hospitals
 
Senior officer who filed this Lobbying Activity Report: Brigitte Nolet
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: